Coverage
-
July 18, 2014
Two employee benefit administrators on Thursday asked a Virginia federal court to transfer to a different division their putative class actions against Pfizer over an alleged generic delay agreement involving Celebrex in order to coordinate similar claims filed by the American Sales Company Inc.
1 other articles on this case.
View all »